Extensive surgical removal of tumor tissue can contribute to longer survival for patients with gliomas. Intraoperative magnetic resonance (iMR) imaging is important for safe and maximal resection of brain tumors. A new operating room equipped with a 1.5-T MR imaging system and neuronavigation opened at Yamagata University Hospital in 2008. Using this new suite, we have safely treated over 200 cases. Use of iMR imaging improved glioma resection rates in 25 (34%) of 73 cases, and gross total resection was achieved in 48 patients (66%). Motor evoked potential (MEP) monitoring was performed in combination with iMR imaging for 32 gliomas. MEP monitoring was successful in 30 cases (94%). Transient decreases in MEP amplitude were seen in two patients. One patient showed transient motor weakness and another showed improvement of motor function. The iMR imaging system provides useful information for tumor resection that allows intraoperative modification of surgical strategies. Combining MEP monitoring with iMR imaging appears to offer the most effective method for safe glioma surgery near eloquent areas.
Introduction
Intraoperative magnetic resonance (iMR) imaging and neuronavigation have substantially changed the principles of surgery for brain tumors. iMR imaging can provide updated information on anatomical structures and unanticipated brain events, thereby allowing safer and more accurate surgery. [1] [2] [3] [4] Our institution installed a fully integrated neurosurgical suite including neuronavigation and an intraoperative 1.5-T high-field MR imaging system (Surgical Suite  ) in 2008. This system provides high-quality images with short scan times. The Surgical Suite  has separate components in the operating room and the MR imaging room, so can be used not only for intraoperative scanning, but also for pre-and postoperative scans and brain checks for inpatients at Yamagata University Hospital. Using this new suite, we have safely treated over 200 cases of brain tumors, including gliomas, metastatic brain tumors, meningiomas, and pituitary adenomas. This study reviews our initial experiences, to evaluate the advantages and limitations of this suite in glioma surgery. Figure 1 shows the appearance of the operating system, Surgical Suite  (GE Healthcare, Milwaukee, Wisconsin, USA). The high-field (1.5-T) MR imaging system (Signa HDx; GE Healthcare) is located in a separate room, which allows us to use standard surgical instruments irrespective of their magnetic properties. Intraoperative MR imaging includes T 1 -weighted, T 2 -weighted, T 2 * -weighted, fluid-attenuated inversion recovery, diffusion-weighted, and T 1 -weighted with gadolinium imaging. If necessary, diffusion tensor imaging can be performed. About 1 hour is needed for iMR imaging, including patient transfer time. Surgical planning was based on multiple sequences of MR imaging performed 1 or 2 days before surgery. Using a navigation planning workstation (iPLAN 2.6; Brainlab AG, Feldkirchen, Germany), target lesions and important anatomical structures were coded as colored objects. Diffusion tensor imaging and functional MR imaging were performed to visualize important tract and functional areas (pyramidal tract, motor cortex, and speech area). If the tumor was located in or around the pyramidal tract and or motor cortex, electrophysiological monitoring such as motor evoked potential (MEP) monitoring was performed by transcortical stimulation using reduction to º50% amplitude compared to before tumor resection as the warning level. If the surgeon considered that the goals of surgery had been met or the risk of injury to a functional area or tract was high, iMR imaging was performed. If iMR imaging indicated incomplete resection, the surgical planning was revised according to the newly obtained images, and the surgical procedure was resumed based on the updated navigation information.
Material and Methods
The extent of resection (EOR) was determined by comparing the MR images obtained before surgery with those obtained within 72 hours after surgery. EOR was calculated based on manual segmentation of the tumor outline in the planning software. Glioma volume was defined as the volume of increased intensity on T 1 -weighted imaging with gadolinium. Tumor volume for non-enhanced tumors was defined as the area of increased intensity on T 2 -weighted imaging. Subtotal or greater resection was defined as a postoperative finding of a À95% reduction in tumor volume.
Results
iMR imaging was performed 225 times during the 202 procedures. The period of interruption for each intraoperative MR imaging session was about 1 hour. The results of iMR imaging affected the surgical strategy in 33 of these 202 cases, including strategies for 25 of 73 gliomas (34%), 3 of 35 pituitary adenomas (8.6%), and 5 of 57 others. Additional removal after iMR imaging was performed in over 50% of cases of non-enhanced tumors and recurrent lesions. Gross total resection was achieved in 66% of 73 glioma cases (n ＝ 48).
Volumetric analysis of primary supratentorial gliomas (n ＝ 40) found that mean initial tumor volumes were 54.9 cm 3 (range 1.2-160.0 cm 3 ) in (Fig. 2) . MEP monitoring was combined with iMR imaging in 32 gliomas. MEP monitoring was successful in 30 cases (94%), and was only unsuccessful in 2 patients with preoperative severe motor weakness. Table 3 shows the results of MEP monitoring and postoperative motor function. Preoperative motor deficits were improved in 4 patients and remained unchanged in 19 patients. Permanent motor deficits were identified in 5 patients, 2 patients with decreased amplitude of MEP and 3 patients with no changes in MEP amplitude. Transient decreases in MEP amplitude were seen in 2 patients. One of these two patients had left temporal glioblastoma and showed transient decreases in MEP amplitude caused by middle cerebral artery compression (Fig.  3) . iMR imaging showed no ischemic changes, but diffusion-weighted imaging after surgery clearly showed an ischemic lesion around the left internal capsule.
Discussion
The present study suggests that the best use for iMR imaging and integrated navigation seems to be for glioma surgery. In our series, 34% of glioma cases were improved and the EOR was increased following iMR imaging. This modality offers particularly important contributions to modification of surgery in non-enhanced and recurrent tumors. In addition, iMR imaging is a good method to overcome technical problems encountered during surgery, such as unclear margins of microscopic and pathological findings and brain shift. In patients with newly diagnosed glioblastomas, increased EOR parallels improvements in overall survival, even at the highest levels of resection, and subtotal resections as low as 78% confer survival benefits. 9) Our results are similar to these findings (Table 1) . In our series, the resection rate of LGG was lower than that of HGG. Three of 7 LGGs were located in eloquent areas, so we intentionally performed partial resection. The resection rates of these cases ranged from 40.7% to 71.9%. Safer resection could be performed for LGG than for HGG considering the long natural history of LGG. Randomized controlled trials of iMR imagingguided glioma surgery did not demonstrate survival benefits. 10) However, iMR imaging guidance in glioma surgery did help surgeons achieve the optimum EOR.
This study analyzed surgical staging and additional (modified) removal after iMR imaging. For tumors classified in stages 1, 2, or 5, no modification was required after iMR imaging. Stage 5 tumors are not resectable to ensure preservation of brain function. In contrast, tumors in stages 3 and 4 underwent the modification after iMR imaging in 15-25% of cases. Moreover, over 50% of recurrent or non-enhanced tumors underwent modification after iMR imaging. iMR imaging is mainly useful for safety management in patients with stage 1, 2, or 5 lesions. Safety management is one of the important purposes of iMR imaging. In our series, we were able to detect left acute subdural hemorrhage during right temporal glioblastoma removal, 7) and could remove the hematoma immediately after tumor resection. The postoperative course was uneventful and the patient remained alive as of 26 months postoperatively.
Review of iMR imaging-guided resection of glioblastoma pointed out the limitations in the available literature, 6) and also suggested cost as an important outcome parameter. Our Surgical Suite  has separate components in the operating room and MR imaging room. Consequently, the system can be used not only for intraoperative imaging, but also for pre-and postoperative imaging and brain checks for inpatients. We have also tried to use iMR imaging in various neurosurgical operations. T 1 -weight-Neurol Med Chir (Tokyo) 52, August, 2012 iMR Imaging and MEP Monitoring in Glioma Surgery ed imaging with gadolinium clearly shows residual tumor in the pituitary region, and intraoperative time-resolved contrast-kinetics imaging can reveal complete resection of arteriovenous malformation without the need for conventional catheter angiography. 8) The present study examined the associations between MEP monitoring and postoperative motor function in 32 patients. MEP monitoring was successful in 30 patients (94%), excluding 2 patients with severe preoperative motor weakness. Preoperative motor deficits recovered in 4 patients, whereas 19 patients showed no changes in motor function. Permanent deficits occurred in 5 patients. We were able to detect decreases in amplitude for 2 patients, but the remaining 3 patients did not show any change in MEP amplitude during surgery. One patient with precentral gyrus glioblastoma suffered motor weakness of the upper limb, and one patient had frontal gliosarcoma. We temporarily clipped the feeding arteries, and checked MEP responses within 20-30 minutes during gliosarcoma removal. We confirmed that MEP responses were unchanged, and then cut the feeder vessels. Postoperative MR imaging revealed an ischemic lesion, including the pyramidal tract. We speculate that the blood supply to the pyramidal tract during surgery was sufficient, but was altered by leptomeningeal anastomosis after surgery. Figure 3 shows the usefulness of MEP monitoring. Compression of the middle cerebral artery caused decrease in MEP amplitude. We were able to prevent permanent deficits based on the warnings provided by MEP monitoring. MEP monitoring is an essential tool for preserving motor function in patients with glioma near the motor cortex or pyramidal tract. We have safely performed 6 awake craniotomies with the use of this iMR imaging system. Combining MEP monitoring with awake craniotomy and iMR imaging appears to offer the most effective method for safe glioma surgery near eloquent areas. Further study of the impact of an iMR imaging system on surgical success and patient survival within the context of a large, prospective, population-based project is needed to confirm the present findings.
The present study shows that iMR imaging provides useful information that allows intraoperative modification of the surgical strategy, and MEP monitoring provides useful information for preserving motor function in patients with gliomas near the primary motor cortex and pyramidal tract. Combined use of iMR imaging, neuronavigation, and MEP monitoring offers the optimal tool for treating brain tumors around the motor cortex or pyramidal tract. This approach could be very helpful for maximizing resection and minimizing morbidity.
